Uncategorized


CEA Industries Announces Pricing of $24 Million Public Offering and Nasdaq Listing

February 10th, 2022 - Ryan Allway

Louisville, Colorado, Feb. 10, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (NASDAQ: CEAD, CEADW) (the “Company”), a leader in controlled environment agriculture (CEA) systems engineering and technologies, today announced the pricing of an underwritten public offering of 5,811,138 shares of the Company’s common stock and warrants to purchase up to 5,811,138 shares of the Company’s common stock […]

Eden Empire Announces Partner to Lead Charge in Michigan Franchise Expansion

January 27th, 2022 - Ryan Allway

VANCOUVER, British Columbia and BATTLE CREEK, Mich., Jan. 27, 2022 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden Empire”) is pleased to announce that it has signed an agreement (the “Agreement”) with an arm’s length third-party (the “Partner”) to assist in expanding the EDEN franchise across the State of Michigan. The […]

OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX

January 21st, 2022 - Ryan Allway

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® […]

PharmAla Biotech Announces Listing on the Canadian Securities Exchange

January 10th, 2022 - Ryan Allway

VANCOUVER, January 10, 2022 (GLOBE NEWSWIRE) – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA), a biotech company focused on the research, development and manufacturing of “psychedelic” pharmaceuticals in the MDXX class, is pleased to announce that the Company’s common shares have been approved for listing on the Canadian Securities Exchange (the “CSE”) […]

Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

December 22nd, 2021 - Ryan Allway

BURLINGTON, Ontario, December 22, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final installment of the Collaborative Research and Development grant, with a value of $120,000, from the […]

Christina Lake Cannabis Corp. Announces Warrant Extension

December 17th, 2021 - Ryan Allway

VANCOUVER, British Columbia, Dec. 17, 2021 (GLOBE NEWSWIRE) — (CSE: CLC) Christina Lake Cannabis Corp. (the “ Corporation ” or “ Christina Lake ”) announces the extension to the expiry date of a total of 6,981,299 outstanding common share purchase warrants (the “ Warrants ”) originally issued as part of a private placement that closed on September 20, 2019 and on […]

Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company

November 24th, 2021 - Ryan Allway

BURLINGTON, Ontario —Nov 24, 2021– Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of one million QuickStrip™ units to one of Canada’s largest cannabis companies.   Three unique formulations – 10mg THC, 20mg CBD and 20mg 1:1 ratio […]

Clearmind Medicine to Pursue Dual Listing on Nasdaq

November 22nd, 2021 - Ryan Allway

Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced that its board of directors has decided to pursue a dual listing […]

Bloomios Shareholder Update & Growth Strategy

November 17th, 2021 - Ryan Allway

SANTA BARBARA, Calif., Nov. 17, 2021 /PRNewswire/ — Bloomios, Inc. (OTC: BLMS), CEO, Michael Hill issued the following letter to shareholders, providing an update on the Company’s developments and future growth strategy.   Bloomios Shareholder Update & Growth Strategy   Dear Shareholders, It is with immense pride that I present this update on our recent corporate activities and strategic initiatives to […]

Schwazze Signs Definitive Agreement to Acquire Smoking Gun, LLC & Smoking Gun Land Company, LLC

November 15th, 2021 - Ryan Allway

Schwazze Continues to widen its Colorado Expansion Strategy DENVER, Nov. 15, 2021 /PRNewswire/ – Schwazze, (OTCQX: SHWZ) (“Schwazze” or the “Company”), announced that it has signed definitive documents to acquire the assets of Smoking Gun, LLC and Smoking Gun Land Company, LLC (“Smoking Gun”).   SCHWAZZE (CNW Group/Medicine Man Technologies, Inc.) The Smoking Gun dispensary and assets are located on a prime retail corner […]

Britannia Completes “Go Public” Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.

November 15th, 2021 - Ryan Allway

TORONTO, Nov. 15, 2021 /CNW/ – Britannia Life Sciences Inc. (BLAB: CSE) (“Britannia“) is pleased to announce the successful completion of its “go public” transaction by way of a reverse take-over (the “RTO“) of RISE Life Science Corp. (“RISE“) (formerly RLSC: CSE). The RTO constituted a “fundamental change” of RISE pursuant to the policies of the Canadian […]

TerrAscend Enters Into Amendment to the Membership Interest Purchase Agreement to Acquire Gage’s Licensed Operators and Extends Proxy Cut-Off for Voting at Special Meeting

November 10th, 2021 - Ryan Allway

Amendment is expected to facilitate and potentially expedite the timeframe in which the conditions for the closing of the Acquisition of Gage may be completed   Deadlines to accept proxies and revocations extended to 12:00 p.m. (Eastern time) on the date of the special meeting, November 11, 2021   TerrAscend encourages all minority shareholders to submit their votes […]

West Island Moves First Shipment of Cannabis to Ontario

November 9th, 2021 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – November 9, 2021) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: MMJFD) (“West Island” or the “Company”) is pleased to announce that West Island subsidiary RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has forwarded its first shipment of OUESTTM brand premium Montreal cannabis to the Province of Ontario. The company has […]

Revitalist Lifestyle Reports Sales Growth of 98% Year Over Year

September 21st, 2021 - Ryan Allway

VANCOUVER, British Columbia, September 21, 2021–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company“) (CSE: CALM) (CSNX: CALM.CN) is pleased to announce its clinic operations generated approximately $632,000 in revenue for the four months ended August 31, 2021, compared to $320,000 for the same period in 2020. The growth represents a 98% increase over […]

Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

September 15th, 2021 - Ryan Allway

Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production   BURLINGTON, Ontario, September 15, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are reporting a preliminary, yet significant milestone in the investigation of an orally delivered vaccine candidate for COVID-19. Today’s report follows the announcement made on […]

Betty’s Eddies® Brand Launches Singles and Brings Back Multi-Packs

September 9th, 2021 - Ryan Allway

NORWOOD, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on health and wellness and improving lives every day, announced today the launch of new SKUs of its top-selling Betty’s Eddies brand of cannabis infused fruit chews. Answering the call of the brand’s […]

IONIC Brands Corp. Announces Record Sales of US$8.3 Million in Second Quarter 2021

August 31st, 2021 - Ryan Allway

Release Highlights Record High Revenue for Second Quarter 2021 (Expressed in US dollars, unless otherwise stated) Record Q2-2021 sales revenues of $8.3M and realized $1.3M in gross profit representing a 16% gross margin for the second quarter 2021, a 1.2% decline on quarter-on-quarter growth due to our combined B2B wholesale business and entrance into the […]

Ayr Wellness Announces 5% Share Buyback, the Maximum Allowed for CSE Listed Companies; Reaffirms 2022 Outlook

August 26th, 2021 - Ryan Allway

Ayr Announces Stock Repurchase Program of up to 5% of Subordinate Voting Shares – the maximum amount allowed for CSE listed companies Reiterates Guidance for 2022 of $800 Million in Revenue and $300 Million in Adjusted EBITDA1 Ayr’s Cash Balance as of June 30, 2021 was $123 Million NEW YORK, Aug. 25, 2021 (GLOBE NEWSWIRE) […]

Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms

August 19th, 2021 - Ryan Allway

TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness ” or the “ Company ”) (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced a $3 million national distribution agreement with Texas-based distribution and advertising company One Light Enterprises LLC. (“ One Light ”) for Silo Wellness’ portfolio of Marley One branded mushroom products […]

Ehave Partners with Globally Recognized University to Target Hallucinogen Persisting Perception Disorder (HPPD)

August 4th, 2021 - Ryan Allway

Partner will gather data and bio markers to create bio lines and revenue model with screening products MIAMI, Aug. 04, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today announced a partnership with a globally recognized university to gather data […]

Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market

July 23rd, 2021 - Ryan Allway

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and many millions still suffer from it. Silo Pharma Inc. (OTCQB: SILO) is a development-stage biopharmaceutical […]

Premium Brand Leader Upping the Ante for Cannabis 2.0 Products

July 21st, 2021 - Ryan Allway

Canada made whole new classes of cannabis products legal for recreational use in October 2019. Hailed as Cannabis 2.0, the introduction of products such as vapes, oils, and edibles was anticipated to offer a new high-growth category in the already booming legal cannabis industry. Due to a variety of factors, including an uneven regulatory rollout […]

Rubicon Organics Provides Operational Update

July 14th, 2021 - Ryan Allway

132% increase in the number of new products available from provincial distributors in Q3, 2021 Simply BareTM Organic top organic brand in all major provinces and maintains leadership in premium category Premium brand 1964 Supply Co.TM has now been accepted in seven provinces Mainstream brand HomesteadTM has been accepted by five provincial distributors   VANCOUVER, British Columbia, July […]

Nasdaq Approves High Tide’s Application to List

May 28th, 2021 - Ryan Allway

High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2nd, 2021 High Tide has received approval from Nasdaq to list its common shares for trading under the symbol “HITI”   CALGARY, May 28th, […]

Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke

May 27th, 2021 - Ryan Allway

VANCOUVER, British Columbia, May 27, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to highlight an independent research study from the University of Szeged in Hungary describing the use of N,N-dimethyltryptamine (“DMT”) in improving outcomes in a rat stroke model. A preprint of the […]

Coming Home: Edmonton-based Dynaleo Inc.’s cannabis-infused soft chews now available in Alberta

May 26th, 2021 - Ryan Allway

EDMONTON, Alberta, May 26, 2021 (GLOBE NEWSWIRE) — Dynaleo, Canada’s highest-capacity manufacturer of premium cannabis-infused soft chews, is proud to announce its Sunshower brand soft chews are now available at AlbertaCannabis.org and at local licensed retailers across the company’s home of province of Alberta. Dynaleo built its head office and state of the art production […]

RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.

May 12th, 2021 - Ryan Allway

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM“) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“Canapar”) and a wholly-owned subsidiary of the […]

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

May 10th, 2021 - Ryan Allway

San Diego, California–(Newsfile Corp. – May 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO), to support Tryp’s clinical development of its Psilocybin-for-Neuropsychiatric Disorders (PFNTM) program.   Clinlogix […]

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

May 4th, 2021 - Ryan Allway

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its previously announced lab services agreement with Numinus Wellness Inc. (“Numinus”) (TSXV: NUMI) is progressing forward with […]

GrowGeneration Announces Belushi’s Farm Partnership

April 30th, 2021 - Ryan Allway

Belushi’s Farm Taps Nation’s Leading Hydroponics Retailer to Outfit New Greenhouse   DENVER, April 30, 2021 /PRNewswire/ – GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGen” or the “Company”) the nation’s largest chain of specialty hydroponic and organic garden centers, today announced a new partnership with Belushi’s Farm to outfit its newest greenhouse. Based in Oregon, Belushi’s Farm was founded in 2015 by performer […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading